Mycenax Biotech
Chemicals & Related Products · Taiwan · 51-200 Employees
View Company Info for Free
Overview
Headquarters
no. 50-7 Keyan Rd Jhunan, Miaoli, Taiwan...Phone Number
+886 37586988Website
www.mycenax.com.twRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Mycenax Biotech
Mycenax is a CDMO specializing in biologics and biosimilars, providing end-to-end services from process development to cGMP-compliant manufacturing. Their core capabilities include bispecific/multispecific antibodies, antibody-drug conjugates (ADCs), and emerging modalities such as cell and gene therapies. The company operates two GMP-compliant facilities, offering comprehensive manufacturing solutions from drug substance (DS) to drug product (DP). Mycenax has been successfully inspected by global regulatory authorities, demonstrating a strong commitment to quality and compliance.Explore more
Mycenax Biotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mycenax Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Mycenax Biotech has new funding data
Click to see if Mycenax Biotech had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Mycenax Biotech
Website visits: Recent activity has been detected on your website
Mycenax Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Mycenax Biotech recently announced quarterly report
Check if Mycenax Biotech has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Mycenax Biotech launches new products
Check out if Mycenax Biotech is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Mycenax Biotech as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Mycenax Biotech is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Mycenax Biotech is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Mycenax Biotech.
Mycenax Biotech Tech Stack
A closer look at the technologies used by Mycenax Biotech
See more technologies
Most Recent Scoops
Person-Based
Product Development, Artificial Intelligence
Person-Based
Partnership
Project
Partnership, Product Management, Business Development, Intellectual Property, Legal Affairs, Healthcare Technology
Person-Based
Person-Based
Mycenax Biotech News & Media
Still's Disease Treatment Market May See a Big Move : Mycenax Biotech, Epirus Biopharmaceuticals, Genor BioPharma, Oncobiologics
Edison, NJ -- (SBWIRE) -- 12/03/2020 -- Latest Market intelligence report released by HTF MI with title "Still's Disease Treatment Market Status and Trend Analysis 2017-2026 (COVID-19 Version)" is designed covering micro level of analysis by manufacturers and key business segments. The Still's Disease Treatment Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary statisBerkeley Lights Makes Debut in Taiwan as Mycenax Acquires the BeaconⓇ Optofluidic System for Cell Line Development
MIAOLI, Taiwan and EMERYVILLE, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Mycenax Biotech, Inc. (4726.TWO), a pioneer of biopharmaceutical development in Taiwan, today announced its adoption of the Berkeley Lights Platform for cell line development. Berkeley Lights, Inc., (Nasdaq: BLI), a leader in Digital Cell Biology, continues to see adoption of the system in Asia Pacific, as Mycenax becomes the first company in Taiwan to use the technology.Hummingbird Bioscience Announces Agreement with Mycenax Biotech for Production of Anti-VISTA Antibody HMBD-002 for Cancer Clinical Trial
HOUSTON, Feb. 20, 2020 /PRNewswire/ -- Hummingbird Bioscience, an innovative biotherapeutics company pioneering the discovery of new breakthrough antibody therapeutics for difficult-to-treat conditions, today announced it has signed an agreement with Mycenax Biotech for the production of...Hummingbird Bioscience Announces Agreement with Mycenax Biotech for Production of Anti-VISTA Antibody HMBD-002 for Cancer Clinical Trial
Hummingbird Bioscience, an innovative biotherapeutics company pioneering the discovery of new breakthrough antibody therapeutics for difficult-to-treat conditions, today announced it has signed an agreement with Mycenax Biotech for the production of material for the Phase 1 clinical trial of its HMBD-002 program which is anticipated to commence in the second half of 2020.
Read more news
Top Chemicals & Related Products Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mycenax Biotech
Sign Up For FreeTo access detailed company insights
Mycenax is a CDMO specializing in biologics and biosimilars, providing end-to-end services from process development to cGMP-compliant manufacturing. Their core capabilities include bispecific/multispecific antibodies, antibody-drug conjugates (ADCs), and emerging modalities such as cell and gene therapies. The company operates two GMP-compliant fac... Read More
